Central obesity index and cardiovascular risk factors in polycystic ovary syndrome;Índices de obesidade central e fatores de risco cardiovascular na síndrome dos ovários policísticos

Arquivos Brasileiros de Cardiologia

Volumn 94, Issue 5, 2010, Pages 633-638

  Costa, Eduardo Caldas ^a   Soares, Elvira Maria Mafaldo ^a   Lemos, Telma Maria Araujo Moura ^a   Maranhão, Técia Maria De Oliveira ^a   Azevedo, George Dantas ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Anthropometry; Cardiovascular disease; Insulin resistance; Polycystic ovary syndrome complications; Risk factors

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

ADULT; ANTHROPOMETRY; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DIET RESTRICTION; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ABDOMINAL OBESITY; BLOOD; CROSS-SECTIONAL STUDY; METHODOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; STANDARD;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPIDS; OBESITY, ABDOMINAL; POLYCYSTIC OVARY SYNDROME; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TRIGLYCERIDES; WAIST-HIP RATIO; YOUNG ADULT;

EID: 77953747931     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/s0066-782x2010005000029     Document Type: Article

References (34)

1. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007; 370: 685-97.
2. Kelly CJG, Cameron IT, Gould GW, Lyall H. The long term health consequences of polycystic ovary syndrome. BJOG. 2000; 107 (11): 1327-38.
3. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Fertil Steril. 2004; 81 (1): 19-25.
4. Park KH, Kim JY, Ahn CW, Song YD, Lim SK, Lee HC. Polycystic ovarian syndrome (PCOS) and insulin resistance. Int J Gynaecol Obstet. 2001; 74 (3): 261-7.
5. Cussons AJ, Stuckey BGA, Watts GF. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis. 2006; 185 (2): 227-39.
6. Cibula D, Cífková F, Fanta M, Poledne R, Zivny J, Skibová J. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod. 2000; 15 (4): 785-9.
7. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation. 2001; 103 (10): 1410-5. (Pubitemid 32220633)
8. Lord J, Thomas R, Fox B, Acharya U, Wilkin T. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG. 2006; 113 (10): 1203-9.
9. Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001; 86 (6): 2453-5.
10. Soares EM, Azevedo GD, Gadelha RG, Lemos TM, Maranhão TM. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome. Fertil Steril. 2008; 89 (3): 649-55.
11. Diamanti-Kandarakis E. Role of obesity and adiposity in polycystic ovary syndrome. Int J Obes (Lond). 2007; 31 (Suppl. 2): S8-S13.
12. Hoeger KM. Obesity and lifestyle management in polycystic ovary syndrome. Clin Obstet Gynecol. 2007; 50 (1): 277-94.
13. Escobar-Morreale HF, San Millán JL. Abdominal obesity and the polycystic ovary syndrome. Trends Endocrinol Metab. 2007; 18 (7): 266-72.
14. Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006; 113 (10): 1148-59.
15. Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U, Müller B. Central fat excess in polycystic ovary syndrome: relation with low-grade inflammation and insulin resistance. J Clin Endocrinol Metab. 2005; 90 (11): 6014-21.
16. Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab. 1999; 84 (4): 1470-4.
17. Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F, De Simone B, et al. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod. 2008; 23 (1): 153-9.
18. Pitanga FJG, Lessa I. Indicadores antropométricos de obesidade como instrumento de triagem para risco coronariano elevado em adultos da cidade de Salvador (Bahia). Arq Bras Cardiol. 2005; 85 (1): 26-31.
19. Azevedo GD, Duarte JM, Souza MO, Costa-E-Silva TD, Soares EM, Maranhão TM. Menstrual cycle irregularity as a marker of cardiovascular risk factors at postmenopausal years. Arq Bras Endocrinol Metab. 2006; 50 (5): 876-83.
20. Pitanga FJG, Lessa I. Indicadores antropométricos de obesidade como discriminadores de risco coronariano elevado em mulheres. Rev Bras Cineantropom Desempenho Hum. 2006; 8 (1): 14-21.
21. Pitanga FJG, Lessa I. Razão cintura-estatura como discriminador do risco coronariano em adultos. Rev Assoc Med Bras. 2006; 52 (3): 157-61.
22. Herrera VM, Casas JP, Miranda JJ, Perel P, Pichardo R, González A, et al. Interethnic differences in the accuracy of anthropometric indicators of obesity in screening for high risk of coronary heart disease. Int J Obes (Lond). 2009; 33 (5): 568-76.
23. Valdez R. A simple model-based index of abdominal adiposity. J Clin Epidemiol. 1991; 44 (9): 955-6.
24. Sociedade Brasileira de Cardiologia. I Diretriz brasileira de diagnóstico e tratamento da síndrome metabólica. Arq Bras Cardiol. 2005; 84 (supl. 1): 3-28.
25. Sociedade Brasileira de Cardiologia. IV Diretriz brasileira sobre dislipidemias e prevenção da aterosclerose. Departamento de aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2007; 88 (supl. 1): 2-19.
26. Orio F Jr, Palomba S, Spinelli L, Cascella T, Tauchmanovà L, Zullo F, et al. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab. 2004; 89 (8): 3696-701.
27. Hsieh SD, Muto T. The superiority of waist-to-height ratio as an anthropometric index to evaluate clustering of coronary risk factors among non-obese men and women. Prev Med. 2005; 40 (2): 216-20.
28. Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr. 2005; 56 (5): 303-7.
29. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation. 1999; 99 (9): 1165-72.
30. Griner PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretation of diagnostic tests and procedures. Ann Intern Med. 1981; 94: 555-600.
31. Lee CMY, Huxley RR, Wildman RP, Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol. 2008; 61 (7): 646-53.
32. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364: 937-52.
33. Yildirim B, Sabir N, Kaleli B. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2003; 79 (6): 1358-64. (Pubitemid 36687882)
34. Almeida RT, Almeida MMG, Araújo TM. Abdominal obesity and cardiovascular risk: performance of anthropometric indexes in women. Arq Bras Cardiol. 2009; 92 (5): 375-80.